Daré Bioscience, Inc. ( DARE ) Q1 2026 Earnings Call May 14, 2026 4:30 PM EDT Company Participants MarDee Haring-Layton - Chief Accounting Officer Sabrina Johnson - CEO, President, Principal Financial Officer, Secretary & Director Conference Call Participants Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Hello, and welcome to the conference call hosted by Dare Bioscience to review the company's first quarter 2026 financial results and to provide a business update. This call is being recorded. My name is King, and I will be your operator today. With us today from Dare are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer. Ms. Haring-Layton, please proceed. MarDee Haring-Layton Chief Accounting Officer Good afternoon, and welcome to the Dare Bioscience financial results and business update call for the quarter ended March 31, 2026.…